Hochschulschrift
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
- Weitere Titel
-
Alzheimer Krankheit: Amyloid Oligomere, therapeutische Agentien, ihre Angriffsziele und Wirkmechanismus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Marburg, Philipps-Universität Marburg, Diss., 2013
- Schlagwort
-
Morbus Alzheimer, Amyloid beta, Oligomere, Antikörper, Nichtsteroidales Antiphlogistikum
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Marburg
- (wer)
-
Philipps-Universität Marburg
- (wann)
-
2013
- Urheber
- Beteiligte Personen und Organisationen
-
Bacher, Michael
- URN
-
urn:nbn:de:hebis:04-z2013-00078
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Balakrishnan, Karthikeyan
- Bacher, Michael
- Philipps-Universität Marburg
Entstanden
- 2013
Ähnliche Objekte (12)
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Alzheimer disease : therapeutic strategies
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Alzheimer disease : therapeutic strategies
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Alzheimer disease : therapeutic strategies
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit